BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38573684)

  • 1. Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
    Öfverholm I; Wallander K; Haglund C; Chellappa V; Wejde J; Gellerbring A; Wirta V; Renevey A; Caceres E; Tsagkozis P; Mayrhofer M; Papakonstantinou A; Linder-Stragliotto C; Bränström R; Larsson O; Lindberg J; Lin Y; Haglund de Flon F
    Clin Cancer Res; 2024 Jun; 30(12):2647-2658. PubMed ID: 38573684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
    Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
    Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors.
    Chebib I; Taylor MS; Nardi V; Rivera MN; Lennerz JK; Cote GM; Choy E; Lozano Calderón SA; Raskin KA; Schwab JH; Mullen JT; Chen YE; Hung YP; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2021 Aug; 45(8):1127-1137. PubMed ID: 34115673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.
    Hiraga H; Nojima T; Abe S; Sawa H; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
    Diagn Mol Pathol; 1998 Apr; 7(2):102-10. PubMed ID: 9785009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.
    Wang GY; Thomas DG; Davis JL; Ng T; Patel RM; Harms PW; Betz BL; Schuetze SM; McHugh JB; Horvai AE; Cho SJ; Lucas DR
    Am J Surg Pathol; 2019 Aug; 43(8):1112-1122. PubMed ID: 30994538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
    Bertram S; Schildhaus HU
    Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.
    Asano N; Matsuzaki J; Ichikawa M; Kawauchi J; Takizawa S; Aoki Y; Sakamoto H; Yoshida A; Kobayashi E; Tanzawa Y; Nakayama R; Morioka H; Matsumoto M; Nakamura M; Kondo T; Kato K; Tsuchiya N; Kawai A; Ochiya T
    Nat Commun; 2019 Mar; 10(1):1299. PubMed ID: 30898996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
    Wunder JS; Czitrom AA; Kandel R; Andrulis IL
    J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology for sarcoma: useful or necessary?].
    Neuville A; Coindre JM; Chibon F
    Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
    Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood sarcomas: fine-needle aspiration cytopathology with an emphasis on the use of molecular studies.
    Wangsiricharoen S; Fuller MY; Wakely PE; Ali SZ
    J Am Soc Cytopathol; 2023; 12(1):20-29. PubMed ID: 36270912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
    Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
    J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular diagnosis of routine sarcomas].
    Coindre JM
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S64-5. PubMed ID: 18984305
    [No Abstract]   [Full Text] [Related]  

  • 20. Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors.
    de Álava E
    Virchows Arch; 2024 Feb; 484(2):353-367. PubMed ID: 38228904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.